Back to search results
NCT04640753

Peroral Endoscopic Myotomy for the Treatment of Achalasia

Recruiting
Not specifiedAges 18+Observational
Methodist Health System
~200 participants
Updated 2026-06-10 on ClinicalTrials.gov
What's tested:Endoscopic procedure for achalasia

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Decrease or no symptoms of chest pain
Measured over upto 180 days

Conditions

Achalasia

Explore related trials

Achalasia

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Prashant Kedia, M.D. · PRINCIPAL_INVESTIGATOR · The Methodist Hospital Research Institute

Who to contact

Crystee Cooper, DHEd
[email protected]
214-947-1280
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any discharged patient who has undergone clinically indicated and/or standard of care POEM for the treatment of Achalasia from 6/2016 to 6/2021.
Above or equal to 18 years of age

Exclusion

Any patient who has not undergone POEM for the treatment of Achalasia.
Below 18 years of age

What this trial measures

  • Decrease or no symptoms of chest painupto 180 days

    To continue and review our treatment outcomes, patient safety in cases with achalasia, we follow up after the procedure up to 180 days. Follow-up period varies from patient to patient.